Business Context and Reporting Period
Company: Xtant Medical Holdings, Inc. (XTNT)
Filing Type: Form 8-K (Current Report)
Date of Report: March 6, 2025
Reporting Period: The filing announces financial results for the three months and full year ended December 31, 2024.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed figures. Consequently, specific numerical values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document.
Non-GAAP Measure Defined: The Company utilizes "Non-GAAP Adjusted EBITDA" to assess core operational performance. This metric is defined as net income/loss adjusted for:
- Depreciation and amortization
- Interest expense and income tax provision/benefit
- Separation-related expenses
- Legal settlements
- Non-cash compensation
- Acquisition-related expenses and fair value adjustments
- Gain on bargain purchase
- Unrealized foreign currency translation gain or loss
Material Changes and Comparisons
The filing text does not provide specific comparative data or material changes versus prior periods. It states that the full text of the press release containing these results is furnished as Exhibit 99.1.
Guidance, Outlook, and Management Commentary
Management Rationale: Management uses Non-GAAP Adjusted EBITDA to facilitate internal comparisons, budgeting, and resource allocation by excluding charges not related to regular, ongoing business (e.g., non-cash charges, legal settlements, and acquisition costs).
Limitations: The Company explicitly states that Non-GAAP measures are not in accordance with GAAP, may differ from measures used by other companies, and should only be used in conjunction with corresponding GAAP measures.
Guidance: No specific forward-looking guidance or outlook is included in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net loss, and cash flow figures for Q4 and Full Year 2024.
- Verify the reconciliation table between Net Loss (GAAP) and Adjusted EBITDA (Non-GAAP) to understand the magnitude of excluded items.
- Confirm the status of separation-related expenses and legal settlements mentioned as exclusions.
- Check for any updated liquidity or debt covenants in the full press release not detailed in this 8-K summary.